CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...